Onkologie. 2009:3(2):80-82

Renal cancer in adults

MUDr. Miroslav Podhola, Ph.D
Fingerlandův ústav patologie FN a LFUK Hradec Králové

Renal cell carcinomas account for 3 % of adult malignancies and 80 % malignant renal tumors. Men are more often affected than women

in a ratio of approximately 2 to 1. The carcinoma arises mainly in adults with a peak in 6th and 7th decade of life. In 5–10 % cases multicentric

tumor is observed and bilateral tumor in 1–6 % respectively. The prognosis is related to several parameters. There is a close correlation

between staging system and outcome. Size of the primary tumor relates to prognosis for the very small (less than 3 cm) and the very

large (over 12 cm) tumors. Nuclear grade of the tumor is an important predictor of survival especially in clear cell carcinoma and papillary

carcinoma. The WHO classification subdivides renal carcinomas into clear cell carcinoma, papillary carcinoma, chromophobe cell

carcinoma, collecting duct carcinoma, medullary carcinoma, renal carcinoma associated with Xp11.2 translocations / TFE3 gene fusions,

mucinous tubular and spindle cell carcinoma and unclassified carcinoma.

Keywords: kidney, renal cell carcinoma, classification.

Published: April 1, 2009  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Podhola M, D P. Renal cancer in adults. Onkologie. 2009;3(2):80-82.
Download citation

References

  1. Kovacs G, Akhtar M, Beckwith B., et al. The Heidelberg classification of renal cell tumours. J Pathol, 1997; 183: 131-133. Go to original source... Go to PubMed...
  2. Störkel S, Eble jn, Adlakha K, et al. Classification of renal carcinoma. Cancer, 1997; 80: 987-989. Go to original source...
  3. Fuhrman SA, Lasky LC, Limas C, et al. Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg pathol, 1982; 6: 655-663. Go to original source... Go to PubMed...
  4. Amin M, Barnabas N, Nanavatir, et al. Granular renal cell carcinoma - not otherwise specified, a distinctive subtype of renal cell carcinoma? An investigation using mutational analysis of von Hippel-Lindau (VHL) gene. Mod Pathol, 1999; 12: 87A.
  5. Weiss LM, Gelb AB, Medeiros LJ. Adult renal epithelial neoplasms. Am J Clin Pathol, 1995; 103: 624-635. Go to original source... Go to PubMed...
  6. Kovacs G, Kovacs A. Parenchymal abnormalities associated with papillary renal cell tumors. J Urol Pathol, 1993; 1: 301-312.
  7. Renshaw AA, Corless CL. Papillary renal cell carcinoma. Am J Surg Pathol, 1995; 19: 842-849. Go to original source... Go to PubMed...
  8. Renshaw AA, Zhang HUA, Corless CL, et al. Solid variants of papillary (chromophil) renal cell carcinoma: clinicopathologic and genetic features. Am J Surg Pathol, 1997; 21: 1203-1209. Go to original source... Go to PubMed...
  9. Delahunt B, Eble JN. Papillary renal cell carcinoma: a clinicopathologic and immunohistochemical study of 105 tumors. Mod Pathol, 1997; 10: 537-544. Go to PubMed...
  10. Akhtar M, Kardar H, Linjawi T, et al. Chromophobe cell carcinoma of the kidney: a clinicopathologic study of 21 cases. Am J Surg Pathol, 1995; 19: 1245-1256. Go to original source... Go to PubMed...
  11. Tickoo SK, Amin MB. Discriminant nuclear features of renal oncocytoma and chromophobe renal cell carcinoma. Analysis of their potential utility in the differential diagnosis. Am J Clin Pathol, 1998; 110: 782-787. Go to original source... Go to PubMed...
  12. Latham B, Dickersin GR, OLIVA E. Subtypes of chromophobe cell renal carcinoma. An ultrastructural and histochemical study of 13 cases. Am J Surg Pathol, 1999; 23: 530-535. Go to original source... Go to PubMed...
  13. Akhtar M, Kfoury H, Kardar A, et al. Sarcomatoid chromophobe cell carcinoma of the kidney. J Urol Pathol, 1996; 4: 155-166.
  14. Akhtar M, Tulbah A, Kardar AH, et al. Sarcomatoid renal cell carcinoma: the chromophobe connection. Am J Surg pathol, 1997; 21: 1188-1195. Go to original source... Go to PubMed...
  15. Kuroda N, Hayashi Y, Itoh H. A case of chromophobe renal cell carcinoma with sarcomatoid foci and a small daughter lesion. Pathol Int, 1998; 48: 812-817. Go to original source... Go to PubMed...
  16. Fuzesi L, Cober M, Mittermayer C, et al. Collecting duct carcinoma: cytogenetic characterization. Histopathology, 1992; 21: 155-160. Go to original source... Go to PubMed...
  17. Avery RA, Harris JE, Davis CJ, et al. Renal medullary carcinoma. Clinical and therapeutic aspects of a newly described tumor. Cancer, 1996; 78: 128-132. Go to original source...
  18. Davis CJ, Mostofi FK, Sesterhenn IA, et al. Renal medullary carcinoma. Am J Surg Pathol, 1995; 19: 1-11. Go to original source... Go to PubMed...
  19. Mai KT, Blew B, Collins JP. Renal cell carcinoma with extensive and minimal sarcomatoid change. J Urol Pathol, 2000; 11: 35-46. Go to original source...
  20. Yang XJ, Zhou M, Hes O, et al. Tubulocystic Carcinoma of the Kidney. Clinicopathologic and Molecular Characterization. Am J Surg Pathol, 2008; 32: 177-187. Go to original source... Go to PubMed...
  21. Michal M, Hes O, Mukenšnábl P. Nádory ledvin dospělého věku. Plzeň, Euroverlag, 2000: 142 s.
  22. Eble JN, Sauter G, Epstein JI, Sesterhenn IA. WHO Classification of tumors. Pathology and Genetics of Tumors of the Urinary System and Male genital Organs. IARC Press, Lyon, 2004.




Oncology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.